LivaNova (LIVN) Competitors $55.43 -0.79 (-1.41%) Closing price 04:00 PM EasternExtended Trading$55.42 -0.01 (-0.01%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. SOLV, PEN, STVN, IRTC, GKOS, BLCO, SLNO, TMDX, NVST, and WRBYShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Envista (NVST), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. LivaNova vs. Its Competitors Solventum Penumbra Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb Soleno Therapeutics TransMedics Group Envista Warby Parker Solventum (NYSE:SOLV) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Which has more risk and volatility, SOLV or LIVN? Solventum has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Does the media favor SOLV or LIVN? In the previous week, Solventum had 10 more articles in the media than LivaNova. MarketBeat recorded 22 mentions for Solventum and 12 mentions for LivaNova. LivaNova's average media sentiment score of 1.37 beat Solventum's score of 0.88 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 9 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, SOLV or LIVN? Solventum has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.54$478M$2.1633.88LivaNova$1.25B2.41$63.23M-$3.89-14.25 Do analysts rate SOLV or LIVN? Solventum presently has a consensus target price of $85.44, suggesting a potential upside of 16.75%. LivaNova has a consensus target price of $59.71, suggesting a potential upside of 7.73%. Given Solventum's higher possible upside, equities analysts clearly believe Solventum is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of SOLV or LIVN? 97.6% of LivaNova shares are held by institutional investors. 0.1% of Solventum shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is SOLV or LIVN more profitable? Solventum has a net margin of 4.52% compared to LivaNova's net margin of -16.13%. Solventum's return on equity of 29.93% beat LivaNova's return on equity.Company Net Margins Return on Equity Return on Assets Solventum4.52% 29.93% 6.65% LivaNova -16.13%14.57%6.91% SummaryLivaNova beats Solventum on 9 of the 17 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.03B$6.69B$5.75B$10.27BDividend YieldN/A1.20%5.72%4.60%P/E Ratio-14.2525.8474.9226.41Price / Sales2.41173.23457.0188.61Price / Cash13.2622.1825.8129.91Price / Book2.284.9413.256.28Net Income$63.23M$176.38M$3.29B$270.38M7 Day Performance-4.96%4.91%0.47%2.70%1 Month Performance3.18%6.39%4.59%5.99%1 Year Performance14.22%10.57%73.41%25.94% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.0536 of 5 stars$55.43-1.4%$59.71+7.7%+15.8%$3.03B$1.25B-14.252,900Positive NewsSOLVSolventum2.1447 of 5 stars$74.62+2.6%$85.75+14.9%+4.7%$12.61B$8.25B34.5522,000Analyst ForecastPENPenumbra4.726 of 5 stars$285.15+1.3%$302.93+6.2%+46.3%$10.98B$1.19B75.844,500Positive NewsSTVNStevanato GroupN/A€25.53+5.7%N/A+37.2%€7.73B€1.19B47.285,521Gap UpIRTCiRhythm Technologies1.2161 of 5 stars$187.07+3.3%$163.82-12.4%+134.7%$5.82B$591.84M-63.852,000Positive NewsGKOSGlaukos4.648 of 5 stars$91.83-2.2%$127.42+38.7%-34.5%$5.39B$383.48M-55.66780Positive NewsBLCOBausch + Lomb2.0891 of 5 stars$15.50+3.3%$15.56+0.3%-2.2%$5.31B$4.79B-19.8813,500SLNOSoleno Therapeutics4.433 of 5 stars$72.30+3.6%$115.09+59.2%+1.5%$3.71BN/A-17.4630Positive NewsShort Interest ↑Analyst RevisionTMDXTransMedics Group2.5734 of 5 stars$105.58+1.5%$122.11+15.7%-24.3%$3.55B$441.54M54.70210NVSTEnvista3.8278 of 5 stars$21.14-0.8%$20.92-1.0%+8.4%$3.54B$2.51B66.0512,300Positive NewsWRBYWarby Parker1.4225 of 5 stars$26.74+2.8%$24.06-10.0%+82.6%$2.74B$771.32M-382.003,780Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies SOLV Alternatives PEN Alternatives STVN Alternatives IRTC Alternatives GKOS Alternatives BLCO Alternatives SLNO Alternatives TMDX Alternatives NVST Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
